Clinical Trials Directory

Trials / Sponsors / Antengene Corporation

Antengene Corporation

Industry · 6 registered clinical trials.

StatusTrialPhaseStarted
TerminatedA Study of ATG-010 in Combination With Lenalidomide and Rituximab (R2) in Adults With DLBCL and iNHL
Diffuse Large B-cell Lymphoma, Indolent Non-Hodgkin Lymphoma
Phase 1 / Phase 22022-04-07
TerminatedA Study of ATG-010 in Combination With ATG-008 in Patients With Relapsed/Refractory Diffuse Large B-cell Lymph
Relapsed/Refractory Diffuse Large B-cell Lymphoma
Phase 12022-03-02
Active Not RecruitingA Study of Evaluating the Safety and Efficacy of ATG-010, Bortezomib, and Dexamethasone (SVd) Versus Bortezomi
Relapsed or Refractory Multiple Myeloma
Phase 32021-07-12
TerminatedA Study of Evaluating the Safety and Efficacy of ATG-010 Combined With Chemotherapy Sequential With ATG-010 Mo
Peripheral T-cell Lymphoma, NK/T-cell Lymphoma
Phase 1 / Phase 22020-08-18
CompletedA Study of Evaluating the Safety and Efficacy of ATG-010 in Relapsed/Refractory Diffuse Large B-Cell Lymphoma
Relapsed/Refractory Diffuse Large B-Cell Lymphoma (DLBCL)
Phase 22020-04-09
CompletedA Study of Evaluating the Safety and Efficacy of ATG-010 in Relapsed Refractory Multiple Myeloma
Relapse/Refractory Multiple Myeloma
Phase 22019-09-02